SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000882104-17-000037
Filing Date
2017-04-28
Accepted
2017-04-28 06:07:48
Documents
10
Period of Report
2017-06-09
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A pdli-042117def14adoc.htm DEF 14A 1195985
2 a2017proxychartb.jpg GRAPHIC 30648
3 a2017proxychartca01.jpg GRAPHIC 44746
4 ceosiga01.jpg GRAPHIC 3893
5 gcsiga01.gif GRAPHIC 2504
6 pdlilogo2016a01.jpg GRAPHIC 59351
7 proxycard1a01.jpg GRAPHIC 236991
8 proxycard2a01.jpg GRAPHIC 233776
9 proxytable1.jpg GRAPHIC 31796
10 proxytablev3.jpg GRAPHIC 33103
  Complete submission text file 0000882104-17-000037.txt   2097513
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 17791531
SIC: 2836 Biological Products, (No Diagnostic Substances)